[Vaccination status in very and extremely preterm infants at the age of 2 years--a nationwide pilot analysis]

B Ziegler1, H-M Strassburg

  • 1Children's University Hospital, General Pediatrics, Josef-Schneider-Strasse 2, Würzburg, Germany.

Klinische Padiatrie
|May 14, 2010
PubMed

Insights

Preterm infants in Germany receive basic immunizations, but often delayed. Booster vaccine rates need improvement, especially in the second year of life, to prevent delays in infant vaccinations.

Area of Science:

  • Pediatrics
  • Immunology
  • Public Health

Context:

  • Preterm infants face higher risks of vaccine-preventable diseases.
  • Timely vaccination is recommended for preterm infants, aligning with full-term infants' schedules.
  • Data on vaccination rates and complications in German preterm infants were previously lacking.

Purpose:

  • To analyze vaccination rates and complications in preterm infants in Germany.
  • To assess adherence to recommended vaccination schedules for preterm infants up to two years of age.
  • To identify delays and challenges in vaccinating very and extremely low birth weight infants.

Summary:

  • This study examined 318 preterm infants (birth weight <1500g) in Germany, analyzing vaccination records and parental questionnaires up to age two.
  • Basic immunizations (pentavalent/hexavalent, pneumococcal, MMR) were largely completed, though often delayed.
  • Booster doses, particularly in the second year of life, showed lower completion rates (89.0% for pentavalent/hexavalent).
  • 17.8% experienced non-severe adverse reactions; no post-immunization apnea episodes were reported.

Impact:

  • Highlights consistent but delayed basic immunization in German preterm infants.
  • Identifies a need to improve booster vaccination rates and prevent overall vaccination delays.
  • Emphasizes the importance of timely immunizations for vulnerable preterm populations to ensure adequate protection against diseases.